Because the expression of MAPK8, MAP3K1, and KRAS genes is significantly upregulated in BC and is associated with the survival of BC patients, MAPK8, MAP3K1, and KRAS genes were selected for follow-up research. The gene discussed is MAP3K1; the disease is breast cancer.